We serve Chemical Name:5-methylmorpholin-3-one CAS:65922-85-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-methylmorpholin-3-one
CAS.NO:65922-85-2
Synonyms:5-Methyl-3-morpholinone;5-METHYL-MORPHOLIN-3-ONE;5-Methyl-3-oxomorpholin;3-Morpholinone, 5-methyl-
Molecular Formula:C5H9NO2
Molecular Weight:115.131
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:290.9±33.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.427
PSA:38.33000
Exact Mass:115.063332
LogP:-1.74
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-Methyl-3-morpholinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Morpholinone, 5-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Morpholinone, 5-methyl- Use and application,5-Methyl-3-morpholinone technical grade,usp/ep/jp grade.
Related News: To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early. 5-methylmorpholin-3-one manufacturer To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early. 5-methylmorpholin-3-one supplier One source familiar with the matter told Reuters that the J&J doses are expected to be exported to other countries. The doses are already in vials and ready for use, the other source said. 5-methylmorpholin-3-one vendor To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early. 5-methylmorpholin-3-one factory As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment.
